ANGIMMUNE
Angimmune is a biotechnology company focused on developing immunotherapies for the treatment of cancer and autoimmune diseases. Utilizing a unique anti-T cell therapy technology, Angimmune designs highly potent immunotoxin molecules. The company's therapeutic approach targets T cell blood cancers, T cell driven autoimmune diseases, and aims to advance immuno-oncology treatments. With a pipeline that includes four clinical trials, Angimmune's research addresses neoplasms and immune system diseases. Founded by experts from the National Institute of Health, the company is dedicated to leveraging its expertise in the field to develop innovative treatments.
ANGIMMUNE
Industry:
Health Care Health Diagnostics Therapeutics
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.angimmune.com
Total Employee:
11+
Status:
Active
Contact:
1 (508) 397-8150
Email Addresses:
[email protected]
Technology used in webpage:
U.S. Server Location
Similar Organizations
Abcuro
Abcuro develops first-in-class immunotherapies to treat autoimmunity and cancer.
Candel Therapeutics
Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.
Aptamer Therapeutics Creative Group
Aptamer Therapeutics Creative Group develops treatments for infectious diseases, autoimmune diseases, and cancer.
Argos Therapeutics
Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.
Cabrellis Pharmaceuticals
Cabrellis Pharmaceuticals Corporation develops therapies for the treatment of cancer.
Cura Therapeutics
Cura Therapeutics offers technology, partnering & collaborations, and pipeline services.
GPER G-1 Development Group
GPER G-1 Development Group develops a novel therapeutic for the treatment of diabetes and obesity.
Ikena Oncology
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
Neurona Therapeutics
Neurona Therapeutics is a provider of cell-based medicines dealing with neurological disorders.
Official Site Inspections
http://www.angimmune.com
- Host name: 209.17.116.160
- IP address: 209.17.116.160
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Angimmune"
About Angimmune - Developer of Resimmune™, an Anti-T Cell …
Angimmune is a clinical stage biotech company founded by Dr. David Neville and two former members of his previous lab at the National Institutes of Health (NIH), Dr. Yuan-Yi Liu and Dr. …See details»
Angimmune - Crunchbase Company Profile & Funding
Angimmune is a biotechnology company focused on developing immunotherapies for the treatment of cancer and autoimmune diseases. Utilizing a unique anti-T cell therapy technology, Angimmune designs highly potent immunotoxin …See details»
Contact Us - Angimmune LLC
Licensing & Clinical Trial Site Inquiries. Paul Neville Director of Operations (508) 397-8150 Email: [email protected]. Licensing Inquiries: China Email: Dr. Yuan-Yi Liu, Ph.D. Angimmune …See details»
Angimmune Company Profile 2024: Valuation, Funding
Angimmune General Information Description. Developer of potency fusion protein anticancer immunotoxin designed for application in T cell blood cancers and autoimmune disease. The …See details»
Angimmune Company Profile | Management and Employees List
Angimmune Profile and History. Angimmune LLC is a Rockville, MD-based biotechnology company focused on researching the role of immunotoxins in the treatment of T-cell related …See details»
Angimmune LLC - Drug pipelines, Patents, Clinical trials - Synapse
Angimmune LLC, a clinical stage biotech venture, was established by Dr. David Neville alongside his colleagues, Dr. Yuan-Yi Liu and Dr. Jung-Hee Woo, leveraging their pioneering …See details»
Angimmune - Overview, News & Similar companies | ZoomInfo.com
Angimmune LLC is a Rockville, MD-based biotechnology company focused on researching the role of immunotoxins in the treatment of T-cell related diseases, including blood and skin …See details»
Angimmune LLC Company Profile | Bethesda, MD - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Angimmune LLC of Bethesda, MD. Get the latest business insights from Dun & Bradstreet.See details»
Angimmune - Crunchbase
Angimmune develops immunotherapies for cancer and autoimmune diseases, focusing on anti-T cell therapy.See details»
Angimmune Company Profile - Office Locations, Competitors
Angimmune is a biotechnology company focused on researching the role of immunotoxins in the treatment of T-cell related diseases, including blood and skin cancers and certain autoimmune …See details»
Angimmune - Company Profile - Tracxn
Nov 27, 2024 Angimmune is a clinical-stage biotech which was founded based on the research on a unique immunotoxin technology developed at the NIH by its founders and is currently …See details»
Angimmune - Company Profile - Tracxn
Angimmune - CDMO focused on anti-cancer proteins development services. Angimmune has 57 competitors.See details»
Angimmune - Overview | aiHit - aiHitdata
Angimmune has exclusively licensed this technology from NIH... According to the CDC, in 2016, nearly 125,000 people in the United States started treatment for end-stage kidney disease, …See details»
Angimmune LLC in Bethesda, MD - (508) 397-8150 - Company …
Angimmune LLC is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»
Angimmune - VentureRadar
Similar Companies: Sun BioPharma USA Privately Held Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and …See details»
Angimmune Bethesda MD, 20814 – Manta.com
Angimmune LLC. UNCLAIMED . This business is unclaimed. Owners who claim their business can update listing details, add photos, respond to reviews, and more. Claim this listing for free. …See details»
Drug granted fast track designation for MF | MDedge
Sep 14, 2016 Resimmune is being developed by Angimmune LLC. Resimmune research. The FDA’s fast track designation for Resimmune is based on results from a phase 1 trial, which …See details»
A-dmDT390-bisFv(National Institutes of Health) - Drug Targets
Dec 5, 2024 Inactive Organization. University of Louisville Angimmune LLC. Drug Highest Phase Phase 2. First Approval Date-Regulation Fast Track (US), Orphan Drug (US) Login to view …See details»
Resimmune - Lymphoma News Today
Resimmune is an investigational treatment for cutaneous T-cell lymphoma (CTCL). It is being developed by Angimmune, a clinical stage biotechnology company investigating the use of …See details»